
Chembio Diagnostics CEMI
Chembio Diagnostics DSO | CEMI
DSO Jährlich Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.3 | 56.6 | 39.6 | 58.4 | 49.9 | 41.6 | 59.3 | 81 | 85.4 | 58.1 | 55.7 | 65.4 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 85.4 | 39.6 | 59.8 |
DSO Vierteljährlich Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 38.7 | 70.4 | 51.7 | - | 36.9 | 38.1 | 30.3 | - | 27.2 | 66.8 | 56.8 | - | 61.5 | 73.5 | 83 | - | 71.4 | 56 | 34.9 | 59.8 | 62.8 | 115 | 65.4 | 81.4 | 107 | 132 | 50.6 | 123 | 122 | 116 | 122 | - | 85.7 | 54 | 62.5 | - | 44.6 | 77.6 | 69 | - | 43.6 | 43.7 | 45.4 | - | 12.7 K | 20.8 K | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 20.8 K | 27.2 | 946 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
109 | $ 13.46 | 1.05 % | $ 142 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 609.81 | -3.81 % | $ 17.6 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
34.9 | - | - | $ 608 M | ||
|
RadNet
RDNT
|
34.5 | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
57.4 | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
43.5 | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
36.4 | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
73.8 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
55.3 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
87 | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
385 | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Guardant Health
GH
|
46.1 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
63.7 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
82.1 | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
66.8 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
48.3 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Fulgent Genetics
FLGT
|
87 | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
62.1 | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
43.9 | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 186.79 | -1.88 % | $ 14.6 B | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 0.13 | -22.11 % | $ 173 K | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 668.26 | -2.95 % | $ 252 B | ||
|
DarioHealth Corp.
DRIO
|
56.7 | $ 1.31 | -9.02 % | $ 5.22 M | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 5.47 | -1.26 % | $ 507 M | ||
|
Precipio
PRPO
|
21.1 | $ 17.46 | -5.6 % | $ 28 M | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 3.58 | -3.38 % | $ 4.74 M | ||
|
QIAGEN N.V.
QGEN
|
65.7 | $ 49.28 | -0.72 % | $ 10.7 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 14.8 | -1.95 % | $ 1.9 B | ||
|
OPKO Health
OPK
|
256 | $ 1.58 | -2.17 % | $ 1.19 B | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.64 | -7.1 % | $ 492 M |